These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29852223)

  • 1. Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development.
    Andersson S; Antonsson M; Elebring M; Jansson-Löfmark R; Weidolf L
    Drug Discov Today; 2018 Oct; 23(10):1733-1745. PubMed ID: 29852223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and Drug Metabolism Properties of Novel Therapeutic Modalities.
    Rock BM; Foti RS
    Drug Metab Dispos; 2019 Oct; 47(10):1097-1099. PubMed ID: 31399505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug.
    Debacker AJ; Voutila J; Catley M; Blakey D; Habib N
    Mol Ther; 2020 Aug; 28(8):1759-1771. PubMed ID: 32592692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ-based drug delivery.
    Alsaggar M; Liu D
    J Drug Target; 2018; 26(5-6):385-397. PubMed ID: 29419330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic oligonucleotides and delivery technologies: Research topics in Japan.
    Murakami M
    Drug Discov Ther; 2016; 10(5):234-235. PubMed ID: 27890898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excipient pharmacokinetics and profiling.
    Loftsson T
    Int J Pharm; 2015 Mar; 480(1-2):48-54. PubMed ID: 25596414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meeting report: oligonucleotide ADME workshop.
    Hood S; Kenworthy D; Christensen JK
    Xenobiotica; 2022 Aug; 52(8):957-961. PubMed ID: 36093882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical potential of oligonucleotide-based therapeutics in the respiratory system.
    Moschos SA; Usher L; Lindsay MA
    Pharmacol Ther; 2017 Jan; 169():83-103. PubMed ID: 27771436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-Targeted Drug Delivery.
    Srinivasarao M; Low PS
    Chem Rev; 2017 Oct; 117(19):12133-12164. PubMed ID: 28898067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Goals, design, timing, and future opportunities for nonclinical drug metabolism studies.
    Miwa GT
    Toxicol Pathol; 1995; 23(2):131-5. PubMed ID: 7569666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotide therapeutics: chemistry, delivery and clinical progress.
    Sharma VK; Watts JK
    Future Med Chem; 2015; 7(16):2221-42. PubMed ID: 26510815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient centric drug product design in modern drug delivery as an opportunity to increase safety and effectiveness.
    Stegemann S
    Expert Opin Drug Deliv; 2018 Jun; 15(6):619-627. PubMed ID: 29719161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted tissue delivery of RNA therapeutics using antibody-oligonucleotide conjugates (AOCs).
    Malecova B; Burke RS; Cochran M; Hood MD; Johns R; Kovach PR; Doppalapudi VR; Erdogan G; Arias JD; Darimont B; Miller CD; Huang H; Geall A; Younis HS; Levin AA
    Nucleic Acids Res; 2023 Jul; 51(12):5901-5910. PubMed ID: 37224533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to improve oral drug bioavailability.
    Gomez-Orellana I
    Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Frontiers in Drug Delivery.
    Tibbitt MW; Dahlman JE; Langer R
    J Am Chem Soc; 2016 Jan; 138(3):704-17. PubMed ID: 26741786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonucleotide delivery: a patent review (2010 - 2013).
    Grijalvo S; Aviñó A; Eritja R
    Expert Opin Ther Pat; 2014 Jul; 24(7):801-19. PubMed ID: 24798406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug delivery system of therapeutic oligonucleotides.
    Asami Y; Yoshioka K; Nishina K; Nagata T; Yokota T
    Drug Discov Ther; 2016; 10(5):256-262. PubMed ID: 27890899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Clicking" Gene Therapeutics: A Successful Union of Chemistry and Biomedicine for New Solutions.
    Astakhova K; Ray R; Taskova M; Uhd J; Carstens A; Morris K
    Mol Pharm; 2018 Aug; 15(8):2892-2899. PubMed ID: 29300491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can colorectal delivery technology provide a platform for enteral oligonucleotide-based therapeutics?
    Murakami M; Watanabe C
    Drug Discov Ther; 2016; 10(5):273-275. PubMed ID: 27890901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.